GenSight is a startup based in the United Kingdom, 6 tracked investors.
Based in the United Kingdom, GenSight is a startup founded in 2012. Brouky records 6 investors associated with the company.
GenSight Biologics is a clinical-stage biotechnology company focused on developing gene therapies to treat neurodegenerative diseases leading to blindness through mitochondrial targeting and optogenetics technologies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.